CanadaTuberculosis profile
Population  2014 36 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.082 (0.081–0.082) 0.23 (0.23–0.23)
Mortality (HIV+TB only) 0.016 (<0.01–0.025) 0.04 (0.03–0.07)
Prevalence  (includes HIV+TB) 2.3 (0.99–4.2) 6.5 (2.8–12)
Incidence  (includes HIV+TB) 1.9 (1.6–2.1) 5.2 (4.6–5.9)
Incidence (HIV+TB only) 0.1 (0.079–0.13) 0.29 (0.22–0.36)
         
Case detection, all forms (%) 84 (74–96)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 1.4 (0.7–2.4) 4.6 (0.96–13)
MDR-TB cases among notified pulmonary
TB cases
14 (8–25) 3 (1–8)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 919   58
Pulmonary, clinically diagnosed 146   3
Extrapulmonary 423   19
       
Total new and relapse 1 568    
Previously treated, excluding relapses 0    
Total cases notified 1 568    
Among 1 568 new and relapse cases:
74 (5%) cases aged under 15 years; male:female ratio: 1.3
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 1 192 (130%) 71 (89%) 1 278
Laboratory-confirmed RR-/MDR-TB cases     21
Patients started on MDR-TB treatment ***     21
TB/HIV 2014 Number (%)
TB patients with known HIV status 803 (51)
HIV-positive TB patients 64 (8)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (82) 1 651
Previously treated cases, excluding relapse, registered in 2013    
HIV-positive TB cases, all types, registered in 2013 (74) 70
RR-/MDR-TB cases started on second-line treatment in 2012 (63) 8
XDR-TB cases started on second-line treatment in 2012   1
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-07-25 Data: www.who.int/tb/data